Market Overview:
The global artificial valve market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of heart diseases, technological advancements in artificial valves, and rising demand for minimally invasive surgeries. The transcatheter valve segment is expected to grow at a CAGR of 6.0% from 2018 to 2030, owing to the increasing demand for minimally invasive surgeries and technological advancements in transcatheter valves.
Product Definition:
An artificial valve is a device which substitutes for a natural heart valve. They are commonly used to treat conditions such as valvular heart disease.
Transcatheter Valve :
Transcatheter valve is a medical device used to treat heart failure and certain types of strokes. It's an alternative to the conventional method of cardiac valve replacement, which involves surgical implantation. Transcatheter valves are made up of materials such as polymeric resins or titanium and can be installed in the heart through minimally invasive techniques like transcatheter pulmonary valve, transcatheter mitral Valve repair & reconstruction or transcatheter aortic Valve replacement (TAVR).
Tissue Valve:
The tissue valve is a type of artificial heart valve used to prevent blood from clotting. It's main function is to allow blood flow through the heart without any problems. The artificial valves are made up of different types of materials such as sutures, polymers, and metallic stents which are placed in the heart by surgeons during open surgery or by using catheters in endoscopic surgeries.
These devices have different sizes.
Application Insights:
The application segment includes a younger than 20 years, ¢â‚¬Å“20 to 30 years old,¢â‚¬ 30-50 years old and above 50. The older population is more susceptible to diseases because of reduced immunity. Therefore, the demand for valves that are suitable for older people has increased. This application segment is expected to witness lucrative growth over the forecast period owing to rising geriatric population across the globe.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D investments by various companies and an increase in healthcare expenditure as well as government funding for such initiatives. In addition, favorable reimbursement policies are also expected to drive growth over the next eight years.
Asia Pacific is anticipated to witness a lucrative growth rate during the forecast period owing to rising disposable income levels, improving healthcare infrastructure, and increasing awareness about advanced products & services among patients & their families and doctors in this region. Moreover, growing medical tourism industry due to low prices offered by countries like India for treatment of heart diseases is further driving demand from other regions of the world (excluding North America). For instance, according with a study published in International Journal of Medical Sciences Case Reports 2015; 2(1): e95-96.
Growth Factors:
- Increasing prevalence of heart diseases and other cardiac disorders that require valve replacement surgeries
- Growing demand for minimally invasive surgical procedures for replacing defective valves
- Rising awareness about the benefits of using artificial valves over traditional mechanical valves
- Technological advancements in the field of artificial valve manufacturing and design
- increasing number of aging population who are at high risk for developing heart diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Artificial Valve Market Research Report
By Type
Transcatheter Valve , Tissue Valve, Mechanical Valve
By Application
<20 Years Old, 20-30 Years Old, 30-50 Years Old, >50 Years Old
By Companies
Colibri Heart Valve, Cytograft Tissue Engineering, Direct Flow Medical, Edwards Lifesciences, Heart Leaflet Technologies, Perouse Medical, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Artificial Valve Market Report Segments:
The global Artificial Valve market is segmented on the basis of:
Types
Transcatheter Valve , Tissue Valve, Mechanical Valve
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
<20 Years Old, 20-30 Years Old, 30-50 Years Old, >50 Years Old
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Colibri Heart Valve
- Cytograft Tissue Engineering
- Direct Flow Medical
- Edwards Lifesciences
- Heart Leaflet Technologies
- Perouse Medical
- ...
Highlights of The Artificial Valve Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transcatheter ValveÂ
- Tissue Valve
- Mechanical Valve
- By Application:
- <20 Years Old
- 20-30 Years Old
- 30-50 Years Old
- >50 Years Old
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Artificial Valve Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Artificial valves are medical devices that help patients with heart conditions breathe. They work by opening and closing to control the flow of air into and out of the lungs.
Some of the key players operating in the artificial valve market are Colibri Heart Valve, Cytograft Tissue Engineering, Direct Flow Medical, Edwards Lifesciences, Heart Leaflet Technologies, Perouse Medical.
The artificial valve market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Valve Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Artificial Valve Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Artificial Valve Market - Supply Chain
4.5. Global Artificial Valve Market Forecast
4.5.1. Artificial Valve Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Artificial Valve Market Size (000 Units) and Y-o-Y Growth
4.5.3. Artificial Valve Market Absolute $ Opportunity
5. Global Artificial Valve Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Artificial Valve Market Size and Volume Forecast by Type
5.3.1. Transcatheter Valve
5.3.2. Tissue Valve
5.3.3. Mechanical Valve
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Artificial Valve Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Artificial Valve Market Size and Volume Forecast by Application
6.3.1. <20 Years Old
6.3.2. 20-30 Years Old
6.3.3. 30-50 Years Old
6.3.4. >50 Years Old
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Artificial Valve Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Artificial Valve Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Artificial Valve Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Artificial Valve Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Artificial Valve Demand Share Forecast, 2019-2029
9. North America Artificial Valve Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Artificial Valve Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Artificial Valve Market Size and Volume Forecast by Application
9.4.1. <20 Years Old
9.4.2. 20-30 Years Old
9.4.3. 30-50 Years Old
9.4.4. >50 Years Old
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Artificial Valve Market Size and Volume Forecast by Type
9.7.1. Transcatheter Valve
9.7.2. Tissue Valve
9.7.3. Mechanical Valve
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Artificial Valve Demand Share Forecast, 2019-2029
10. Latin America Artificial Valve Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Artificial Valve Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Artificial Valve Market Size and Volume Forecast by Application
10.4.1. <20 Years Old
10.4.2. 20-30 Years Old
10.4.3. 30-50 Years Old
10.4.4. >50 Years Old
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Artificial Valve Market Size and Volume Forecast by Type
10.7.1. Transcatheter Valve
10.7.2. Tissue Valve
10.7.3. Mechanical Valve
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Artificial Valve Demand Share Forecast, 2019-2029
11. Europe Artificial Valve Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Artificial Valve Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Artificial Valve Market Size and Volume Forecast by Application
11.4.1. <20 Years Old
11.4.2. 20-30 Years Old
11.4.3. 30-50 Years Old
11.4.4. >50 Years Old
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Artificial Valve Market Size and Volume Forecast by Type
11.7.1. Transcatheter Valve
11.7.2. Tissue Valve
11.7.3. Mechanical Valve
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Artificial Valve Demand Share, 2019-2029
12. Asia Pacific Artificial Valve Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Artificial Valve Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Artificial Valve Market Size and Volume Forecast by Application
12.4.1. <20 Years Old
12.4.2. 20-30 Years Old
12.4.3. 30-50 Years Old
12.4.4. >50 Years Old
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Artificial Valve Market Size and Volume Forecast by Type
12.7.1. Transcatheter Valve
12.7.2. Tissue Valve
12.7.3. Mechanical Valve
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Artificial Valve Demand Share, 2019-2029
13. Middle East & Africa Artificial Valve Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Artificial Valve Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Artificial Valve Market Size and Volume Forecast by Application
13.4.1. <20 Years Old
13.4.2. 20-30 Years Old
13.4.3. 30-50 Years Old
13.4.4. >50 Years Old
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Artificial Valve Market Size and Volume Forecast by Type
13.7.1. Transcatheter Valve
13.7.2. Tissue Valve
13.7.3. Mechanical Valve
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Artificial Valve Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Artificial Valve Market: Market Share Analysis
14.2. Artificial Valve Distributors and Customers
14.3. Artificial Valve Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Colibri Heart Valve
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cytograft Tissue Engineering
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Direct Flow Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Edwards Lifesciences
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Heart Leaflet Technologies
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Perouse Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ...
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook